Atossa Therapeutics ATOS

$ 0.97 -0.55%

Quarterly report 2024-Q3
added 11-12-2024

Atossa Therapeutics Balance Sheet 2011-2024 | ATOS

Annual Balance Sheet Atossa Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-39.6 M	-12.5 M	-10.4 M	-7.22 M	-3.03 M	-3.72 M	-8.38 M	-6.32 M	-1.73 M	-906 K
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	18.1 K	39.4 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	11.1 K	-	-	-	-	51.7 K	-	-	-
Total Current Liabilities	5.24 M	5.57 M	3.13 M	15.7 M	1.32 M	2.92 M	1.23 M	1.05 M	2.5 M	2.21 M	1.41 M	1.65 M	-
Total Liabilities	5.24 M	5.57 M	3.13 M	15.7 M	1.33 M	2.92 M	1.23 M	1.05 M	2.5 M	2.27 M	1.41 M	1.65 M	1.51 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	48.2 K	-	-
Retained Earnings	-186 M	-156 M	-129 M	-	-94.1 M	-76.8 M	-65.4 M	-57.3 M	-50.9 M	-35.2 M	-20.5 M	-9.73 M	-4.65 M
Total Assets	96.3 M	124 M	141 M	42.8 M	14.5 M	11.7 M	8.16 M	4.14 M	6.24 M	11.8 M	12 M	6.83 M	3.07 M
Cash and Cash Equivalents	88.5 M	111 M	136 M	39.6 M	12.6 M	10.4 M	7.22 M	3.03 M	3.72 M	8.5 M	6.34 M	1.73 M	1.91 M
Book Value	91 M	118 M	138 M	27.2 M	13.2 M	8.81 M	6.94 M	3.1 M	3.74 M	9.5 M	10.6 M	5.18 M	1.56 M
Total Shareholders Equity	91 M	118 M	138 M	27.2 M	13.2 M	8.81 M	6.94 M	3.1 M	3.74 M	9.5 M	10.6 M	5.18 M	1.56 M

All numbers in USD currency

Quarterly Balance Sheet Atossa Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.22 K	4.72 K	8.01 K	11.1 K	11.1 K	11.1 K	11.1 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12.5 K	25.2 K	49.2 K	-	49.2 K	49.2 K	5.82 K	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	5.8 M	5.7 M	5.33 M	5.24 M	3.44 M	3.48 M	2.94 M	5.57 M	2.87 M	3.79 M	2.32 M	3.13 M	1.68 M	-	-	15.7 M	15.7 M	1.83 M	916 K	1.33 M	1.33 M	1.33 M	1.33 M	2.92 M	2.92 M	2.92 M	2.92 M	-	-	-	-	1.05 M	-	-	-	2.5 M	3.3 M	3.44 M	3.52 M	2.27 M	2.27 M	2.27 M	2.27 M	1.41 M	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-205 M	-198 M	-192 M	-186 M	-179 M	-172 M	-162 M	-156 M	-149 M	-141 M	-134 M	-129 M	-124 M	-119 M	-112 M	-112 M	-112 M	-112 M	-112 M	-94.1 M	-94.1 M	-94.1 M	-94.1 M	-76.8 M	-76.8 M	-76.8 M	-76.8 M	-65.4 M	-65.4 M	-65.4 M	-65.4 M	-57.3 M	-57.3 M	-57.3 M	-57.3 M	-50.9 M	-50.9 M	-50.9 M	-50.9 M	-35.2 M	-35.2 M	-35.2 M	-35.2 M	-20.5 M	-20.5 M	-20.5 M	-20.5 M	-9.73 M	-9.73 M	-9.73 M	-9.73 M	-4.65 M	-4.65 M	-	-
Total Assets	79.5 M	85.9 M	91.1 M	96.3 M	102 M	108 M	116 M	124 M	127 M	134 M	137 M	141 M	143 M	146 M	141 M	42.8 M	42.8 M	42.8 M	42.8 M	14.5 M	14.5 M	14.5 M	14.5 M	11.7 M	11.7 M	11.7 M	11.7 M	8.16 M	8.16 M	8.16 M	8.16 M	4.14 M	4.14 M	4.14 M	4.14 M	6.24 M	6.24 M	6.24 M	6.24 M	11.8 M	11.8 M	11.8 M	11.8 M	12 M	12 M	12 M	12 M	6.83 M	6.83 M	6.83 M	6.83 M	3.07 M	3.07 M	-	-
Cash and Cash Equivalents	74.8 M	79.5 M	84 M	88.5 M	94 M	99.4 M	104 M	111 M	117 M	126 M	131 M	136 M	140 M	142 M	138 M	39.6 M	39.6 M	39.6 M	39.6 M	12.6 M	12.6 M	12.6 M	12.6 M	10.4 M	10.4 M	10.4 M	10.4 M	7.22 M	7.22 M	7.22 M	7.22 M	3.03 M	3.03 M	3.03 M	3.03 M	3.72 M	3.72 M	3.72 M	3.72 M	8.5 M	8.5 M	8.5 M	8.5 M	6.34 M	6.34 M	6.34 M	6.34 M	1.73 M	1.73 M	1.73 M	1.73 M	1.91 M	1.91 M	-	-
Book Value	73.7 M	80.2 M	85.8 M	91 M	98.3 M	105 M	113 M	118 M	124 M	130 M	135 M	138 M	141 M	146 M	141 M	27.2 M	27.2 M	41 M	41.9 M	13.2 M	13.2 M	13.2 M	13.2 M	8.81 M	8.81 M	8.81 M	8.81 M	8.16 M	8.16 M	8.16 M	8.16 M	3.1 M	4.14 M	4.14 M	4.14 M	3.74 M	2.95 M	2.81 M	2.72 M	9.5 M	9.5 M	9.5 M	9.5 M	10.6 M	12 M	12 M	12 M	6.83 M	6.83 M	6.83 M	6.83 M	3.07 M	3.07 M	-	-
Total Shareholders Equity	73.7 M	80.2 M	85.8 M	91 M	98.3 M	105 M	113 M	118 M	124 M	130 M	135 M	138 M	141 M	144 M	140 M	27.2 M	27.2 M	27.2 M	27.2 M	13.2 M	13.2 M	13.2 M	13.2 M	8.81 M	8.81 M	8.81 M	8.81 M	6.94 M	6.94 M	6.94 M	6.94 M	3.1 M	3.1 M	3.1 M	3.1 M	3.74 M	3.74 M	3.74 M	3.74 M	9.5 M	9.5 M	9.5 M	9.5 M	10.6 M	10.6 M	10.6 M	10.6 M	5.18 M	5.18 M	5.18 M	5.18 M	1.56 M	1.56 M	-	-

All numbers in USD currency